Clinical Trial Update: Ziftomenib in Combination With Chemotherapy for Children With Relapsed/Refractory Acute Leukemia [Phase 1]

View source ↗

Summary

Phase 1 pediatric trial evaluating ziftomenib in combination with chemotherapy for relapsed/refractory acute leukemia in children is currently recruiting, inclu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kmt2a-rearranged Acute Leukemia
• Npm1-mutant Acute Leukemia
• Nup98-rearranged Acute Leukemia

Drugs mentioned

• Ziftomenib (ziftomenib)

Snippet

Sponsor: PedAL BCU, LLC | Conditions: Relapsed/Refractory KMT2A-r Acute Leukemia, Relapsed/Refractory NUP98-r Acute Leukemia | Phase 1 | Status: RECRUITING